Parathyroid hormone-related protein (PTH-P) undergoes extensive posttranslational endoproteolytic processing in the pancreatic islet to yield a family of at least four distinct mature peptides. One of the endoproteolytic processing sites appears to be a single basic amino acid, Arg37, the cleavage of which leads to the generation of PTHrP(1-36) and a mid-region form of the peptide which begins at Ala38. Following this and a number of other complex posttranslational processing steps, mature PTHrPs are secreted by a large number of different cell types, some of which employ the regulated secretory pathway, and others of which typically employ the constitutive secretory pathway. The pathways through which the various mature PTHrP secretory forms are secreted in the pancreatic islet, as is the case in other cell types, is unknown. In addition, while it is now well established that the PTHrP gene is expressed in the pancreatic islet, its function in the islet is unknown. In order to study the normal physiologic role of PTHrP in the pancreatic islet in vivo, we have developed a transgenic mouse model in which PTHrP is targeted to, and overexpressed in, the pancreatic beta cell using the rat insulin promoter (RIP). These RIP-PTHrP mice have only recently been established, but already display a striking phenotype: they appear to be hypoglycemic relative to their normal littermates, have a high perinatal mortality, and are markedly stunted in size.
The aims of this proposal follow from the above considerations and are: 1. To study the role of monobasic endoproteolytic posttranslational processing enzymes in the posttranslational processing of PTHrP in the pancreatic beta cell, and to study the mechanisms of secretion of PTHrP by the pancreatic beta cell. 2. To evaluate the physiologic roles of PTHrP in the pancreatic islet using a) pancreatic beta cell-targetted, PTHrP-overexpressing transgenic mice, and b) the PTHrP """"""""knockout"""""""" mouse. Preliminary data summarized within the proposal indicate that the reagents and techniques required to accomplish these goals are available in the applicant's laboratory. Identification of the processing steps: and secretory mechanisms of PTHrP as well as its normal physiologic role in the islet will have critical importance, and may well yield insight into the regulation of insulin secretion and the pathogenesis and treatment of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK047168-01A1
Application #
2146493
Study Section
General Medicine B Study Section (GMB)
Project Start
1995-02-15
Project End
1998-11-30
Budget Start
1995-02-15
Budget End
1995-11-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Fiaschi-Taesch, Nathalie M; Santos, Soledad; Reddy, Vasumathi et al. (2004) Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 15:112-25
Garcia-Ocana, Adolfo; Takane, Karen K; Reddy, Vasumathi T et al. (2003) Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278:343-51
Siddique, Aleem; Malo, Madhu S; Ocuin, Lee M et al. (2003) Convergence of the thyroid hormone and gut-enriched Kruppel-like factor pathways in the context of enterocyte differentiation. J Gastrointest Surg 7:1053-61; discussion 1061
Cebrian, Ana; Garcia-Ocana, Adolfo; Takane, Karen K et al. (2002) Overexpression of parathyroid hormone-related protein inhibits pancreatic beta-cell death in vivo and in vitro. Diabetes 51:3003-13
Luparello, C; Romanotto, R; Tipa, A et al. (2001) Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells. J Bone Miner Res 16:2173-81
Garcia-Ocana, A; Vasavada, R C; Cebrian, A et al. (2001) Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-62
Garcia-Ocana, A; Vasavada, R C; Takane, K K et al. (2001) Using beta-cell growth factors to enhance human pancreatic Islet transplantation. J Clin Endocrinol Metab 86:984-8
Vasavada, R C; Garcia-Ocana, A; Zawalich, W S et al. (2000) Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275:15399-406
Garcia-Ocana, A; Takane, K K; Syed, M A et al. (2000) Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226-32
Porter, S E; Sorenson, R L; Dann, P et al. (1998) Progressive pancreatic islet hyperplasia in the islet-targeted, parathyroid hormone-related protein-overexpressing mouse. Endocrinology 139:3743-51

Showing the most recent 10 out of 16 publications